MetLife, Inc. $MET Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC cut its position in shares of MetLife, Inc. (NYSE:MET) by 6.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 352,186 shares of the financial services provider’s stock after selling 24,962 shares during the quarter. Voya Investment Management LLC owned 0.05% of MetLife worth $29,010,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of MET. Delta Investment Management LLC lifted its position in shares of MetLife by 0.9% in the first quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock valued at $1,145,000 after acquiring an additional 133 shares in the last quarter. Ignite Planners LLC raised its stake in MetLife by 2.2% in the 2nd quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock valued at $491,000 after purchasing an additional 136 shares during the last quarter. Legacy Capital Wealth Partners LLC lifted its holdings in MetLife by 3.2% in the 2nd quarter. Legacy Capital Wealth Partners LLC now owns 4,355 shares of the financial services provider’s stock valued at $350,000 after purchasing an additional 137 shares in the last quarter. Glenview Trust co boosted its stake in shares of MetLife by 0.4% during the 1st quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock worth $3,078,000 after purchasing an additional 141 shares during the last quarter. Finally, Iowa State Bank grew its holdings in shares of MetLife by 0.3% during the third quarter. Iowa State Bank now owns 47,937 shares of the financial services provider’s stock worth $3,949,000 after buying an additional 147 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

MET stock opened at $81.54 on Friday. The company has a market cap of $53.72 billion, a PE ratio of 15.36, a price-to-earnings-growth ratio of 0.78 and a beta of 0.76. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. The stock has a 50-day moving average price of $78.50 and a two-hundred day moving average price of $78.88. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $88.09.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The business had revenue of $12.46 billion for the quarter, compared to analyst estimates of $18.64 billion. During the same period in the previous year, the company posted $1.95 EPS. The company’s revenue was down 5.9% compared to the same quarter last year. As a group, research analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th were paid a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a yield of 2.8%. The ex-dividend date was Tuesday, November 4th. MetLife’s payout ratio is currently 42.75%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Piper Sandler downgraded shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price objective on the stock. in a research note on Friday, September 19th. Barclays raised their price objective on MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Mizuho assumed coverage on MetLife in a research note on Monday, December 15th. They issued an “outperform” rating and a $101.00 target price for the company. Wells Fargo & Company decreased their price target on MetLife from $96.00 to $92.00 and set an “overweight” rating on the stock in a research note on Friday, November 7th. Finally, Morgan Stanley set a $101.00 price objective on shares of MetLife and gave the company an “overweight” rating in a research note on Monday, December 15th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.55.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.